These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32988414)

  • 41. Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review.
    Fujiwara M; Shimizu M; Okano T; Maejima Y; Shimomura K
    Front Public Health; 2023; 11():1264056. PubMed ID: 38106883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.
    Ishiguro A; Ogata D; Ohashi K; Hiki K; Yamakawa K; Jinnai S; Tsutsui K; Takahashi A; Namikawa K; Yamazaki N
    Medicine (Baltimore); 2022 Sep; 101(35):e30398. PubMed ID: 36107581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
    Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
    Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case report.
    Seo JH; Lim T; Ham A; Kim YA; Lee M
    Medicine (Baltimore); 2022 Sep; 101(35):e30456. PubMed ID: 36107574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: A case report and literature review.
    Huang X; Yang M; Wang L; Li L; Zhong X
    Medicine (Baltimore); 2021 May; 100(19):e25795. PubMed ID: 34106616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Association between diabetic ketoacidosis and acromegaly].
    Ocampo P; Duarte JM; Barcia R; Arévalo C
    Medicina (B Aires); 2018; 78(2):131-133. PubMed ID: 29659365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors.
    Heck A; Winge-Main AK
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34045201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer.
    Yamagata S; Kageyama K; Takayasu S; Asari Y; Makita K; Terui K; Daimon M
    Intern Med; 2019 Dec; 58(24):3557-3562. PubMed ID: 31462588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
    Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
    Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenal Insufficiency and Thyrotoxicosis Following Combined Immune Checkpoint Inhibitor Use: A Case Report and Literature Review.
    Fukushima K; Kitayama S; Sazuka M; Kodera R; Oba K; Toyoshima K; Chiba Y; Yamamoto H; Araki A; Tamura Y
    Cureus; 2024 May; 16(5):e60850. PubMed ID: 38910605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
    Iglesias P; Sánchez JC; Díez JJ
    Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event.
    Doodnauth AV; Klar M; Mulatu YS; Malik ZR; Patel KH; McFarlane SI
    Cureus; 2021 Jun; 13(6):e15465. PubMed ID: 34123679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
    J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
    Kurokawa K; Mitsuishi Y; Shimada N; Ito N; Ogiwara M; Miura K; Asao T; Ko R; Shukuya T; Shibayama R; Goto H; Takahashi K
    Thorac Cancer; 2023 Feb; 14(5):442-449. PubMed ID: 36523162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T
    In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Case of Type 2 Diabetes Mellitus with Lung Cancer Suffered from Euglycemic Diabetic Ketosis Accompanied by Adrenal Insufficiency after Immune Checkpoint Inhibitors.
    Shibasaki S; Noda C; Imagawa A; Sakane S
    Case Rep Endocrinol; 2024; 2024():9982174. PubMed ID: 38414717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
    Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
    BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
    Furubayashi N; Negishi T; Uozumi T; Takamatsu D; Shiraishi K; Hirose D; Nakamura M
    Mol Clin Oncol; 2019 Feb; 10(2):304-308. PubMed ID: 30680212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma.
    Salangsang J; Sapkota S; Kharel S; Gupta P; Kalla A
    Cureus; 2023 Feb; 15(2):e35276. PubMed ID: 36825072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer.
    Nagai T; Mogami T; Takeda T; Tomiyama N; Yasui T
    Urol Case Rep; 2021 Nov; 39():101766. PubMed ID: 34285878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.